BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Santos P, Almeida F. Exosome-Based Vaccines: History, Current State, and Clinical Trials. Front Immunol 2021;12:711565. [PMID: 34335627 DOI: 10.3389/fimmu.2021.711565] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 15.0] [Reference Citation Analysis]
Number Citing Articles
1 Greening DW, Xu R, Ale A, Hagemeyer CE, Chen W. Extracellular vesicles as next generation immunotherapeutics. Semin Cancer Biol 2023;90:73-100. [PMID: 36773820 DOI: 10.1016/j.semcancer.2023.02.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Feng Q, Zhang Y, Fang Y, Kong X, He Z, Ji J, Yang X, Zhai G. Research progress of exosomes as drug carriers in cancer and inflammation. J Drug Target 2023;31:335-53. [PMID: 36543743 DOI: 10.1080/1061186X.2022.2162059] [Reference Citation Analysis]
3 Young Chung J, Thone MN, Davies JE, Gach JS, Huw Davies D, Forthal DN, Kwon YJ. Vaccination against SARS-CoV-2 using extracellular blebs derived from spike protein-expressing dendritic cells. Cell Immunol 2023;386:104691. [PMID: 36822152 DOI: 10.1016/j.cellimm.2023.104691] [Reference Citation Analysis]
4 Hernández-Díazcouder A, Díaz-Godínez C, Carrero JC. Extracellular vesicles in COVID-19 prognosis, treatment, and vaccination: an update. Appl Microbiol Biotechnol 2023;107:2131-41. [PMID: 36917275 DOI: 10.1007/s00253-023-12468-6] [Reference Citation Analysis]
5 Thakur A. Shedding Lights on the Extracellular Vesicles as Functional Mediator and Therapeutic Decoy for COVID-19. Life (Basel) 2023;13:840. [PMID: 36983995 DOI: 10.3390/life13030840] [Reference Citation Analysis]
6 Amarasinghe I, Phillips W, Hill AF, Cheng L, Helbig KJ, Willms E, Monson EA. Cellular communication through extracellular vesicles and lipid droplets. J of Extracellular Bio 2023;2. [DOI: 10.1002/jex2.77] [Reference Citation Analysis]
7 Tang YL, Li DD, Duan JY, Sheng LM, Wang X. Resistance to targeted therapy in metastatic colorectal cancer: Current status and new developments. World J Gastroenterol 2023; 29(6): 926-948 [DOI: 10.3748/wjg.v29.i6.926] [Reference Citation Analysis]
8 Pordanjani PM, Bolhassani A, Milani A, Pouriayevali MH. Extracellular vesicles in vaccine development and therapeutic approaches for viral diseases. Process Biochemistry 2023. [DOI: 10.1016/j.procbio.2023.02.028] [Reference Citation Analysis]
9 Rehman FU, Liu Y, Zheng M, Shi B. Exosomes based strategies for brain drug delivery. Biomaterials 2023;293:121949. [PMID: 36525706 DOI: 10.1016/j.biomaterials.2022.121949] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Safadi DE, Lebeau G, Lagrave A, Mélade J, Grondin L, Rosanaly S, Begue F, Hoareau M, Veeren B, Roche M, Hoarau JJ, Meilhac O, Mavingui P, Desprès P, Viranaïcken W, Krejbich-Trotot P. Extracellular Vesicles Are Conveyors of the NS1 Toxin during Dengue Virus and Zika Virus Infection. Viruses 2023;15. [PMID: 36851578 DOI: 10.3390/v15020364] [Reference Citation Analysis]
11 Fujita H, Ohta S, Nakamura N, Somiya M, Horie M. Progress of Endogenous and Exogenous Nanoparticles for Cancer Therapy and Diagnostics. Genes (Basel) 2023;14. [PMID: 36833186 DOI: 10.3390/genes14020259] [Reference Citation Analysis]
12 Lee I, Choi Y, Shin DU, Kwon M, Kim S, Jung H, Nam GH, Kwon M. Small Extracellular Vesicles as a New Class of Medicines. Pharmaceutics 2023;15. [PMID: 36839647 DOI: 10.3390/pharmaceutics15020325] [Reference Citation Analysis]
13 Liu Z, Zhang H, Liu S, Hou Y, Chi G. The Dual Role of Astrocyte-Derived Exosomes and Their Contents in the Process of Alzheimer's Disease. J Alzheimers Dis 2023;91:33-42. [PMID: 36373321 DOI: 10.3233/JAD-220698] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Mahl L, Ollig J, Schweihofer V, Wiegand L, Torkler P, Haerteis S, Aung T. Importance and implications of exosomes in nephrology and urology. Pflugers Arch 2023;475:153-66. [PMID: 36399151 DOI: 10.1007/s00424-022-02771-y] [Reference Citation Analysis]
15 Sadeghi S, Tehrani FR, Tahmasebi S, Shafiee A, Hashemi SM. Exosome engineering in cell therapy and drug delivery. Inflammopharmacology 2023;31:145-69. [PMID: 36609717 DOI: 10.1007/s10787-022-01115-7] [Reference Citation Analysis]
16 Chen X, Li H, Song H, Wang J, Zhang X, Han P, Wang X. Meet changes with constancy: Defence, antagonism, recovery, and immunity roles of extracellular vesicles in confronting SARS-CoV-2. J Extracell Vesicles 2022;11:e12288. [PMID: 36450704 DOI: 10.1002/jev2.12288] [Reference Citation Analysis]
17 Alia Moosavian S, Hashemi M, Etemad L, Daneshmand S, Salmasi Z. Melanoma-derived exosomes: Versatile extracellular vesicles for diagnosis, metastasis, immune modulation, and treatment of melanoma. International Immunopharmacology 2022;113:109320. [DOI: 10.1016/j.intimp.2022.109320] [Reference Citation Analysis]
18 Rech J, Getinger-panek A, Gałka S, Bednarek I. Origin and Composition of Exosomes as Crucial Factors in Designing Drug Delivery Systems. Applied Sciences 2022;12:12259. [DOI: 10.3390/app122312259] [Reference Citation Analysis]
19 Zhang Y, Li D, Lu S, Zheng B. Toxoplasmosis vaccines: what we have and where to go? NPJ Vaccines 2022;7:131. [PMID: 36310233 DOI: 10.1038/s41541-022-00563-0] [Reference Citation Analysis]
20 Yue J, Chen ZS, Xu XX, Li S. Functions and therapeutic potentials of exosomes in osteosarcoma. Acta Mater Med 2022;1:552-62. [PMID: 36710945 DOI: 10.15212/amm-2022-0024] [Reference Citation Analysis]
21 Mustajab T, Kwamboka MS, Choi DA, Kang DW, Kim J, Han KR, Han Y, Lee S, Song D, Chwae Y. Update on Extracellular Vesicle-Based Vaccines and Therapeutics to Combat COVID-19. IJMS 2022;23:11247. [DOI: 10.3390/ijms231911247] [Reference Citation Analysis]
22 Gao X, Gao B, Li S. Extracellular vesicles: A new diagnostic biomarker and targeted drug in osteosarcoma. Front Immunol 2022;13:1002742. [DOI: 10.3389/fimmu.2022.1002742] [Reference Citation Analysis]
23 Wang Q, Wang Z, Sun X, Jiang Q, Sun B, He Z, Zhang S, Luo C, Sun J. Lymph node-targeting nanovaccines for cancer immunotherapy. J Control Release 2022;351:102-22. [PMID: 36115556 DOI: 10.1016/j.jconrel.2022.09.015] [Reference Citation Analysis]
24 Clinton NA, Ageboh NJ, Nkache BD, Mencha ES, Aminkeng A, Ndobegang EJ, Ivo EM, Vigha SR, Ekabe CJ, Fan C. Harnessing the Therapeutic Potential of Exosomes: A Novel Strategy for Anticancer and Antiviral Therapy. BioMed Research International 2022;2022:1-11. [DOI: 10.1155/2022/3356467] [Reference Citation Analysis]
25 Chen X, Feng J, Chen W, Shao S, Chen L, Wan H. Small extracellular vesicles: from promoting pre-metastatic niche formation to therapeutic strategies in breast cancer. Cell Commun Signal 2022;20:141. [PMID: 36096820 DOI: 10.1186/s12964-022-00945-w] [Reference Citation Analysis]
26 Guo X, Sui R, Piao H. Tumor-derived small extracellular vesicles: potential roles and mechanism in glioma. J Nanobiotechnology 2022;20:383. [PMID: 35999601 DOI: 10.1186/s12951-022-01584-6] [Reference Citation Analysis]
27 Huang Y, Li X, Yang L. Mesenchymal stem cells and their derived small extracellular vesicles for COVID-19 treatment. Stem Cell Res Ther 2022;13:410. [PMID: 35962458 DOI: 10.1186/s13287-022-03034-4] [Reference Citation Analysis]
28 Li L, Zhou J, Dong X, Liao Q, Zhou D, Zhou Y. Dendritic cell vaccines for glioblastoma fail to complete clinical translation: Bottlenecks and potential countermeasures. Int Immunopharmacol 2022;109:108929. [PMID: 35700581 DOI: 10.1016/j.intimp.2022.108929] [Reference Citation Analysis]
29 Lu B, Ku J, Flojo R, Olson C, Bengford D, Marriott G. Exosome- and extracellular vesicle-based approaches for the treatment of lysosomal storage disorders. Adv Drug Deliv Rev 2022;:114465. [PMID: 35878794 DOI: 10.1016/j.addr.2022.114465] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
30 Ng CY, Kee LT, Al-masawa ME, Lee QH, Subramaniam T, Kok D, Ng MH, Law JX. Scalable Production of Extracellular Vesicles and Its Therapeutic Values: A Review. IJMS 2022;23:7986. [DOI: 10.3390/ijms23147986] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
31 Shimon MB, Shapira S, Seni J, Arber N. The Big Potential of Small Particles: Lipid-Based Nanoparticles and Exosomes in Vaccination. Vaccines 2022;10:1119. [DOI: 10.3390/vaccines10071119] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Zeng Y, Qiu Y, Jiang W, Shen J, Yao X, He X, Li L, Fu B, Liu X. Biological Features of Extracellular Vesicles and Challenges. Front Cell Dev Biol 2022;10:816698. [DOI: 10.3389/fcell.2022.816698] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
33 Fu W, Li T, Chen H, Zhu S, Zhou C. Research Progress in Exosome-Based Nanoscale Drug Carriers in Tumor Therapies. Front Oncol 2022;12:919279. [DOI: 10.3389/fonc.2022.919279] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Chen H, Sun T, Jiang C. Extracellular vesicle-based macromolecule delivery systems in cancer immunotherapy. J Control Release 2022;348:572-89. [PMID: 35714733 DOI: 10.1016/j.jconrel.2022.06.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Hao D, Lopez J, Chen J, Iavorovschi AM, Lelivelt NM, Wang A. Engineering Extracellular Microenvironment for Tissue Regeneration. Bioengineering 2022;9:202. [DOI: 10.3390/bioengineering9050202] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Domínguez Rubio AP, D'Antoni CL, Piuri M, Pérez OE. Probiotics, Their Extracellular Vesicles and Infectious Diseases. Front Microbiol 2022;13:864720. [PMID: 35432276 DOI: 10.3389/fmicb.2022.864720] [Reference Citation Analysis]
37 Mas-bargues C, Borrás C, Alique M. The Contribution of Extracellular Vesicles From Senescent Endothelial and Vascular Smooth Muscle Cells to Vascular Calcification. Front Cardiovasc Med 2022;9:854726. [DOI: 10.3389/fcvm.2022.854726] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Kumar P, Boyne C, Brown S, Qureshi A, Thorpe P, Synowsky SA, Shirran S, Powis SJ. Tumour-associated antigenic peptides are present in the HLA class I ligandome of cancer cell line derived extracellular vesicles. Immunology 2022. [PMID: 35318648 DOI: 10.1111/imm.13471] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
39 Bond ST, Calkin AC, Drew BG. Adipose-Derived Extracellular Vesicles: Systemic Messengers and Metabolic Regulators in Health and Disease. Front Physiol 2022;13:837001. [PMID: 35283789 DOI: 10.3389/fphys.2022.837001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
40 Ortiz-Bonilla CJ, Uccello TP, Gerber SA, Lord EM, Messing EM, Lee YF. Bladder Cancer Extracellular Vesicles Elicit a CD8 T Cell-Mediated Antitumor Immunity. Int J Mol Sci 2022;23:2904. [PMID: 35328324 DOI: 10.3390/ijms23062904] [Reference Citation Analysis]
41 Szwedowicz U, Łapińska Z, Gajewska-Naryniecka A, Choromańska A. Exosomes and Other Extracellular Vesicles with High Therapeutic Potential: Their Applications in Oncology, Neurology, and Dermatology. Molecules 2022;27:1303. [PMID: 35209095 DOI: 10.3390/molecules27041303] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
42 Hsu MT, Wang YK, Tseng YJ. Exosomal Proteins and Lipids as Potential Biomarkers for Lung Cancer Diagnosis, Prognosis, and Treatment. Cancers (Basel) 2022;14:732. [PMID: 35158999 DOI: 10.3390/cancers14030732] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
43 Lee J, Lee J, Chakraborty K, Hwang J, Lee Y. Exosome-based drug delivery systems and their therapeutic applications. RSC Adv 2022;12:18475-92. [DOI: 10.1039/d2ra02351b] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Chen Y, Zheng X, Wu C. The Role of the Tumor Microenvironment and Treatment Strategies in Colorectal Cancer. Front Immunol 2021;12:792691. [PMID: 34925375 DOI: 10.3389/fimmu.2021.792691] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
45 Tominaga N. Anti-Cancer Role and Therapeutic Potential of Extracellular Vesicles. Cancers (Basel) 2021;13:6303. [PMID: 34944923 DOI: 10.3390/cancers13246303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
46 Yang P, Peng Y, Feng Y, Xu Z, Feng P, Cao J, Chen Y, Chen X, Cao X, Yang Y, Jie J. Immune Cell-Derived Extracellular Vesicles – New Strategies in Cancer Immunotherapy. Front Immunol 2021;12:771551. [DOI: 10.3389/fimmu.2021.771551] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
47 Teng Y, Gao L, Loveless R, Rodrigo JP, Strojan P, Willems SM, Nathan CA, Mäkitie AA, Saba NF, Ferlito A. The Hidden Link of Exosomes to Head and Neck Cancer. Cancers (Basel) 2021;13:5802. [PMID: 34830956 DOI: 10.3390/cancers13225802] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
48 Xia Z, Qing B, Wang W, Gu L, Chen H, Yuan Y. Formation, contents, functions of exosomes and their potential in lung cancer diagnostics and therapeutics. Thorac Cancer 2021. [PMID: 34734680 DOI: 10.1111/1759-7714.14217] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]